Design and characterization of allantoin-inducible expression systems in budding yeast

出芽酵母中尿囊素诱导表达系统的设计与表征

阅读:4

Abstract

BACKGROUND: Saccharomyces cerevisiae has been extensively employed as a host for the production of various biochemicals and recombinant proteins. The expression systems employed in S. cerevisiae typically rely on constitutive or galactose-regulated promoters, and the limited repertoire of gene expression regulations imposes constraints on the productivity of microbial cell factories based on budding yeast. RESULTS: In this study, we designed and characterized a series of allantoin-inducible expression systems based on the endogenous allantoin catabolic system (DAL-related genes) in S. cerevisiae. We first characterized the expression profile of a set of DAL promoters induced by allantoin, and further combined with the galactose-inducible (GAL) system to create a highly responsive genetic switch that efficiently amplifies the output signals. The resulting allantoin-GAL system could give a ON/OFF ratio of 68.6, with 6.8-fold higher signal output over that of direct P(DAL2)-controlled gene expression. Additionally, when a centromeric plasmid was used for EGFP expression, the ON/OFF ratio was increased to > 67.2, surpassing the EGFP expression levels driven by the DAL2 promoter. Subsequently, we successfully demonstrated that allantoin-GAL system can be used to effectively regulate carotenoid production and cell flocculation in S. cerevisiae. CONCLUSIONS: In summary, we characterized several allantoin-inducible DAL promoters from budding yeast and further developed a layered allantoin-GAL system that utilizes the DAL2 promoter to regulate the galactose regulon in budding yeast. The resulting allantoin-GAL system could give an impressive ON/OFF ratio that surpassed the traditional P(DAL2)-controlled gene expression. It is anticipated that utilizing our allantoin-inducible system in budding yeast with allantoin as the alternative nitrogen source might favor the low-cost production of biochemicals and pharmaceuticals.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。